A VISIONaerie™ approach
We discover, develop, and commercialize first-in-class therapies for the treatment of patients with glaucoma, retinal diseases and other diseases of the eye
Press ReleaseAerie Pharmaceuticals Initiates Netarsudil Ophthalmic Solution Phase 2... Aerie Pharmaceuticals Initiates Phase 2 Clinical Trial of AR-1105... Aerie Pharmaceuticals Announces U.S. FDA Approval of Rocklatan™...
Mar 22, 4:00 PM ET
52 - WEEK LOW/HIGH